2-Butyn-1-ol → HCID 58610431, compound
Reaction equation
CS([C:5]1[N:9]=[C:8]([CH:10]2[CH2:15][CH2:14][CH:13]([CH3:16])[CH2:12][CH2:11]2)[S:7][N:6]=1)(=O)=O.[CH2:17]([OH:21])[C:18]#[C:19][CH3:20].[H-].[Na+]>CN(C)C=O.[Cl-].[Na+].O>[CH3:16][CH:13]1[CH2:14][CH2:15][CH:10]([C:8]2[S:7][N:6]=[C:5]([O:21][CH2:17][C:18]#[C:19][CH3:20])[N:9]=2)[CH2:11][CH2:12]1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
400 mg of 3-methylsulfonyl-5-(4-methylcyclohexyl)-1,2,4-thiadiazole and 129 mg of 2-butyn-1-ol were dissolved in 3 ml of N,N-dimethylformamide, 80 mg of sodium hydride (60% in oil) was added thereto under ice-cooling, and the reaction mixture was stirred for 1 hour under ice-cooling and for 12 hours at room temperature. Then, the reaction mixture was added to saturated brine, and extracted with t-butyl methyl ether. The organic layer was concentrated under reduced pressure, and the residue obtained was subjected to silica gel column chromatography to give 258 mg of 5-(4-methylcyclohexyl)-3-(2-butynyloxy)-1,2,4-thiadiazole (hereinafter referred to as the present invention compound (12)).
Workup
- temperatureunder ice-cooling
- extractionextracted with t-butyl methyl ether
- concentrationThe organic layer was concentrated under reduced pressure
- customthe residue obtained
Sources & evidence
- ORD record
- ord-3255b1adb4744e6296c2bf26876e6e84
- Source dataset
- uspto-grants-2007_11
- Patent number
- US07301032B2
Reaction notes
Loading…